Back to search
FDAFDA · Food and drugs·Recall number Z-1162-2013

Sirtex SIR-yttrium 90 microspheres (Radionuclide); SIR-Y001. Indicated for the treatment of unresectable metastatic liver tumors.

Published May 1, 2013 · Recall initiated: February 27, 2013

Summary

FDA records medical device Class III recall Z-1162-2013, published May 1, 2013 and initiated February 27, 2013. Recalling firm: Sirtex Medical Limited; Status: Terminated; Reported quantity: 21 doses; Lot: Batch HB024V02 to HB024V14; Batch HB025V02 to HB024V10. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect expiration date

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sirtex Medical Limited
Distributor
Nationwide Distribution-USA (nationwide) including DC and the states of AZ, CA, CT, GA, ID, IL,KY, LA, MD, ME, MO, MT, NJ, NV, WA, and WV.
Lot
Batch HB024V02 to HB024V14; Batch HB025V02 to HB024V10
Risk classification
Class III
Area (FDA)
device
Country
Australia

Related recalls

Questions about this recall

Was Sirtex SIR-yttrium 90 microspheres (Radionuclide); SIR-Y001. Indicated for the treatment of unresectable metastatic liver tumors. recalled?

Yes. FDA published recall Z-1162-2013 on May 1, 2013. Reported hazard: Incorrect expiration date

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit